Honasa Consumer Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/9thjpkq0fwnkxqatdjuhrly3.pdf

Key Takeaways


Distribution Transition: The Deliberate Topline Headwind

Varun Alagh: "the impact that we are seeing is in our primary sales, which is what I talked about, for example, last quarter, about 200 basis points in primary sales is the impact over the next three quarters, we believe 50 to 100 basis points every quarter will be the impact on this"

Mamaearth: The Core Brand's Growth Algorithm

Varun Alagh: "I must clarify that our LUP is largely actually categorized as MUP. Because we will not get into sachets as a company, given we have aspirational brands, and we would like to maintain that aspiration."

House of Brands: Scaling Beyond the Flagship

Varun Alagh: "if there is an opportunity to disrupt, and that disruption cannot be done by one of our existing brands because of the because of the sharpness or architecture required to do it then we would surely look at newer brands to cater to that because we have proven our ability to create value by building a newer brand."

Margin Expansion: The 150 bps Roadmap


Competitive Posture & Quality Moat

Varun Alagh: "We are paranoid about quality in this company. We started as a baby care company, we used to make products for our own babies. And we still continue to test everything ourselves as well."

Guidance & Commitments

CommitmentSpecificsTimeline
Company growth20% plus value growth CAGRNext 3 years; FY25 included
EBITDA margin expansionAt least 150 bps improvement over FY24FY25
Distribution transition drag50-100 bps primary sales impact per quarter; super stockist layer reduced from 50% to 30%Next 3 quarters
Mamaearth growthDouble-digit value CAGRNext 2 years
Derma Co offline contributionReach high single digitsFY25
Cosmogenesis Labs deal closureAcquisition completedNext 4-6 weeks
Saudi legal appeal filingAppeal filed against court of first instance judgmentWithin 30 days
Derma Co revenue milestoneEnter INR1,000 crores clubNext 3-5 years
Aqualogica and Dr. Sheth's revenue milestoneEnter INR500 crores club eachNext 3-5 years
BBlunt revenue milestoneEnter INR250 crores clubNext 3-5 years

Key Metrics

MetricQ4 FY24
Revenue growth (like-for-like)23%, with underlying volume growth of 27%
Underlying volume growth (UVG)27%
EBITDA margin7%, compared to negative EBITDA in Q4 FY23
Profit after tax (quarterly)₹30 cr, highest ever quarterly profit
Free cash flow (quarterly)₹80 cr
Revenue growth (like-for-like, FY24)31.5%
EBITDA margin (FY24)7.1%, improved from 1.5% in FY23
PAT (FY24)₹111 cr
UVG (FY24)41%
Free cash flow (FY24)₹224 cr
Offline channel contribution~33% of sales for FY24
NPD contribution to revenue18% of FY24 revenue from operations
Mamaearth UVG growth (FY24)Mid-teens
The Derma Co ARR (net sales value)₹500 cr, GMV close to ₹900 cr
Distribution transition impact on primary sales~200 bps in Q4, 50–100 bps expected per quarter over next three quarters
Super stockist level~50% at quarter end, objective to reduce to 30% over next three quarters
Mamaearth market share gain (face wash, Nielsen)120 bps in FY24
Mamaearth market share gain (shampoo, Nielsen)40 bps in FY24
Share among handlers gain (face wash)150 bps
Share among handlers gain (shampoo)65 bps
Honasa sunscreen market share (ecommerce)>30%
Active-based subcategory size~₹2,000 cr ARR
Derma Co + Dr. Sheth's share of active-based subcategory33–35%
Baby care salience for Mamaearth~10%
Skin segment share of company value>60%, fastest-growing segment
Modern trade and institutional share within offline~40%, GT ~60%
FY25 margin improvement targetAt least 150 bps improvement over FY24
FY25 growth target20%+ CAGR